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Peribulbar blockAbstract Aim: The study conducted aims to assess the efﬁcacy, time to ﬁrst analgesic request, and
postoperative inﬂammatory response after adding dexamethasone to local anesthetic mixture for a
peribulbar block in posterior segment eye surgery.
Patients and methods: A double-blind randomized study was carried out on 50 ASA I and II
patients scheduled for elective posterior segment surgery (vitreoretinal). Patients were allocated ran-
domly into two groups, 25 patients in each group. Group I received equal volumes of 10 ml of a l:1
mixture of bupivacaine 0.5% and saline, supplemented with 4 mg dexamethasone in 1 ml saline and
group II received the same local anesthetic mixture (total volume 10 ml) without adding dexameth-
asone. The duration and onset of motor block, time to ﬁrst analgesic request, postoperative inﬂam-
matory response, and other side effects such as nausea and vomiting were assessed.
Results: Patients receiving peribulbar block were signiﬁcantly pain free by end of surgery (0 h)
(P< 0.05) and throughout the postoperative period in the dexamethasone group at 2 and 6 h postop-
eratively. The number of patients requiring rescue analgesics was signiﬁcantly lower with dexameth-
asone bupivacaine block (P< 0.05). The incidence of postoperative nausea and vomiting was
signiﬁcantly less in the ﬁrst group (I) in comparison to the other group (II) (P< 0.05) and lastly
the level of C reactive protein postoperatively was found to be signiﬁcantly less in the dexamethasone
group than the other one (P< 0.0001).
Conclusion: Adding dexamethasone to bupivacaine in peribulbar block appears to be a safe and clin-
ically superior adjuvant with less postoperative pain, inﬂammatory response in patients undergoing
posterior segment eye surgery.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.D license.








Age (years) 53.6 ± 12.3 56.2 ± 11.9
Weight (kg) 72.9 ± 9.5 69.7 ± 8.8
Sex (M/F) 13/10 11/12
Duration of surgery (min) 105.6 ± 27.3 111.3 ± 24.2
Data are expressed as mean + SD, or number percent.
P> 0.05 (non-signiﬁcant).
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Themajorityofophthalmicprocedures areperformedunder local
anesthesia as the patient being often elderly with
inter-current diseases. Moreover, it is associated with less hemo-
dynamic instability, less respiratory depression, better postopera-
tive pain relief, and less nausea and vomiting
than general anesthesia [1]. The lack of need to fast and the
possibility for diabetics to remain on their normal regimes, the
reduction in stress response, maintained oxygen saturation and
cardiovascular stability, adding to this, the production of good
akinesia and anesthesia alleviating occulo-medullary reﬂexes, all
make local anesthesia more superior and safe technique [2].
Surgeries for posterior segment are lengthy procedures and
associated with relatively signiﬁcant postoperative pain [3].
The addition of adjuvant to local anesthesia (LA) in peribulbar
block could be a method to prolong the duration of the block.
Many drugs had been added including opioids, clonidine, keta-
mine, and dexamethasone. All could be injected either intrathe-
cally, extradurally, or into the peripheral nerves [4,5]. Yet, all
have side effects either hemodynamic instability, increased intra-
ocular pressure, respiratory depression as well as gastro-intesti-
nal side effects. Peribulbar block is a much simpler, rapid, and
safe technique, especially in elderly patients [6] whom the use
of general anesthesia and narcotics is usually done with caution.
Dexamethasone is a high potency, long acting glucocorti-
coid with little mineralocorticoid effect [7]. Glucocorticoids
have been used to reduce inﬂammation and for prevention of
postoperative nausea and vomiting; they are also effective in
reducing postoperative pain and edema [8].
2. Patients and methods
Fifty adult patients, American Society of Anesthesiology
(ASA) I or II, scheduled for elective vitreous body surgery
or surgery for retinal detachment with or without scleral buck-
ling were included in the study.
Patients were informed by the risks and beneﬁts of peribul-
bar block. Patients were excluded from the study if they had
any orbital deformity, high myopes, increased intraocular
pressure, or if they were blind in the contralateral eye. Other
exclusion criteria were known allergy to local anesthetics, con-
traindication to steroids, mentally retarded patients, or pa-
tient’s refusal. The study was conducted at Aldemerdash
hospital, ophthalmology operating theatre from June 2012 till
January 2013.
After approval of the hospital medical committee, an in-
formed consent was obtained from the patients. All patients
were premedicated with oral midazolam 1–2 mg 1 h before
applying the local anesthesia. Patients were randomly allo-
cated to either of two groups using closed envelopes method.
After routine monitoring, a medial canthus single peribulbar
block was performed using a total volume of 10 ml of 0.5%
bupivacaine local anesthetic added to it 4 mg dexamethasone
disodium phosphate (in 1 ml) for the bupivacaine-dexametha-
sone group (group I, N= 25), while the other group received
peribulbar block using 10 ml of 0.5% bupivacaine only (group
II, N= 25).
Short beveled ﬁne needles (25-gauge) were used for reduc-
ing pain on needle insertion and to enhance the tactile percep-
tion of resistance during needle insertion (intraneural orintramuscular placement). Ocular compression was performed
for 5 min. Further intraoperative and postoperative monitor-
ing was performed by investigators who were unaware of the
group differences.
Hemodynamic variables (heart rate, systolic blood pres-
sure, diastolic blood pressure) 5 min after administration of
analgesic deﬁned baseline were monitored continuously. Lid
akinesia was assessed by asking the patient to open his eye lids
and squeezing them together maximally. It was recorded as
grade 1 if there was no resistance of the lids on attempted clo-
sure, as grade 2 if there was mild resistance of the lid margins,
and as grade 3 if there was an appearance of creases at the out-
er canthus [10].
On the other hand, ocular motility was recorded for four
quadrants, gaze in the superior, inferior, medial, and lateral
directions, using a three-point scale system, where (0 = no
movement, 1 = reduced movement, and 2 = normal move-
ment). A score of up to 2 suggested a successful block [11].
The onset and duration of lid and globe akinesia were assessed.
At the end of the procedure, pain assessment was done (0 h,
at end of surgery) then postoperatively at 2, 6, and 12 h. In
each group, pain assessment using 10 points pain scale
(VAS) and postoperative complications were assessed and
compared.
Tool for pain assessment is the 0–10 Pain Scale (VAS), with
numeric values ascribed to pain level, where 0 represents no
pain and 10 is the worst pain imaginable.
Patients with VAS (pain score) more than 2 and up to 4
were treated by procetamol (1 g) intravenously. For a score
of 4 or more, meperidine 1 mg/kg was administered by intrave-
nous route and the patients transferred to the ward when
comfortable.
Degree of postoperative inﬂammation was assessed among
the patients and compared between the two groups, using level
of C reactive protein which was measured preoperatively and
24 h postoperatively.
Postoperative nausea and vomiting was monitored and was
managed by metoclopramide 10 mg intravenously.
3. Results
Fifty patients were enrolled in the study. Two patients from
group I (bupivacaine–dexamethasone group) were agitated
after local injection and received general anesthesia were ex-
cluded from the study. The two groups were comparable with
respect to patients’ demographic data and duration of surgery
(Table 1). There was no statistically signiﬁcant difference be-
Table 2 Onset of akinesia (globe and lid).
Group I (dexamethasone + bupivacaine) N= 23 Group II (bupivacaine) N= 25 P value
Lid akinesia (min) 2.76 ± 1.1\ 2.8 ± 1.2 P= 0.905
Globe akinesia (min) 7.6 ± 2.00\\ 8.14 ± 1.56 P= 0.300
P value > 0.05 Non-signiﬁcant\ Non-signiﬁcant\\
Data are expressed as mean + SD.
Table 3 Duration of akinesia (globe and lid).
Group I N= 23 Group II N= 25 P value
Lid akinesia (min) 158.26 ± 13.42 148.52 ± 12.61 P= 0.012\
Globe akinesia (min) 188.16 ± 12.35 179.02 ± 11.58 P= 0.011
P value < 0.05 Signiﬁcant\ Signiﬁcant
Data are expressed as mean + SD.
Table 4 Pain assessment at 2, 6, and 12 h postoperatively. (Number of patients who were pain free postoperatively).
Time 0 H 2 H 6 H 12 H
Group I (dexamethasone + bupivacaine) N= 23 21/23 19/23 21 /23 23/23
(91.3%) (82.6%) (91.3%) (100)
Group II (Bupivacaine) N = 25 20/25 12/25 15 /25 23/25
(80%) (48%) (60) (92)
P value P= 0.48 P= 0.027\ P= 0.03\ P= 0.507
Non-signiﬁcant Signiﬁcant Signiﬁcant Non-signiﬁcant
Data are expression as number percent.
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nesia (p> 0.05, Table 2).
The duration of lid akinesia was longer (158.26 ±
13.42 min.) in group I than in group II (148.52 ± 12.61 min.)
and this was statistically signiﬁcant (P< 0.05) (Table 3). Also,
the duration of globe akinesia was longer (188.16 ±
12.35 min.) in group I than in group II (179.02 ± 11.58 min.)
and this was statistically signiﬁcant (P< 0.05) (Table 3).
Number of patients who were pain free was less in group II
at 2, 6 h postoperatively, in comparison with group I and this
was statistically signiﬁcant (P< 0.05) (Table 4), and they were
almost non-signiﬁcantly different at 12 h duration postopera-
tively. The number of patients requiring postoperative analge-
sia at 2, 6 h postoperatively were signiﬁcantly less in group I
(bupivacaine–dexamethasone group) (P< 0.05) (Table 5);
moreover, the time to ﬁrst analgesic request was signiﬁcantly
longer in group I (P< 0.05) than in group II (Table 5).
The inﬂammatory response to the surgery was assessed
postoperatively by measuring the levels of C – reactive protein
which was signiﬁcantly less in group I in comparison with
group II P< 0.05) (Table 6). As regard postoperative nausea
and vomiting, in group 1 (bupivacaine–dexamethasone group)
only one patient developed nausea and vomiting while in
group II 3 patients, and this was statistically non-signiﬁcant
(P> 0.05) (Table 7).
Results are expressed as means ± standard deviation (SD)
or number percent (%). Comparison between numerical datawas performed using student t-test. Comparison between cate-
gorical data was performed using the chi-squared test. Data
were considered signiﬁcant if p values were <0.05. Statistical
analysis was performed with the aid of the MEDCALC com-
puter program (version 12 windows).
4. Discussion
Our study was a prospective, double blinded, randomized
study. The primary outcome was the effect of dexamethasone
on the duration and quality of peribulbar block and the sec-
ondary outcome was the conﬁrmation of the efﬁcacy of adding
dexamethasone for prolongation of postoperative analgesia
and the anti-inﬂammatory effect as well. Dexamethasone was
not used before as an adjuvant to local anesthetic for ophthal-
mic block but used alone intravitreally, subconjunctival, and in
peribulbar injection [12].
The results of our study indicate that the addition of dexa-
methasone to bupivacaine for peribulbar block in posterior
segment surgery had led to prolongation of duration of lid
and globe akinesia; the time of ﬁrst rescue analgesia was de-
layed together with prolonged postoperative analgesic dura-
tion indicated by prolonged duration of akinesia and VAS.
The result of our study is in agreement with the analgesia
effects of preoperative administration of dexamethasone and
other glucocorticoids given by oral, intravenous, intramuscu-
Table 5 Comparison between dexamethasone group and the bupivacaine group in no. of patients requiring analgesia postoperative
(pain score > or equal 4 on VAS) also time for ﬁrst analgesic request.
0 H 2 H 6 H 12 H
















P value P= 0.073 P= 0.015\ P= 0.037\ P= 0.5
Group I (N= 23) Group II (N= 25) P value
Time to ﬁrst analgesia request (h) 3.15 ± 0.41 2.55 ± 1.32 P= 0.042\
Data was expressed as mean ± SD, or number percent (%).
Statistically signiﬁcant \P value < 0.05 signiﬁcant.
P value < 0.05 = non-signiﬁcant.
Table 6 Inﬂammatory response assessment postoperatively, using C reactive protein levels (lg/dl).
Preoperatively 24 h Postoperatively
Group I (dexamethasone + bupivacaine) N= 23 1.39 ± 1.46 6.37 ± 2.11 lg/mL
Group II (bupivacaine) N= 25 1.62 ± 1.84 15.63 ± 3.14 lg/mL
P value =0.635 Non-signiﬁcant P< 0.0001 highly signiﬁcant
Data are expressed as mean + SD.
Table 7 Postoperative nausea and vomiting.
Group I N= 23 Group II N= 25
Nausea and vomiting 1/23 3/25
P> 0.05 (=0.671) Non-signiﬁcant Non-signiﬁcant
Data are expressed as number percent. (P> 0.05) = non-
signiﬁcant.
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block [13] or epidural analgesia [14] in patients undergoing
gynecological operations [15], dental extraction [16], laparo-
scopic cholecystectomy [17], and foot surgeries [18].
The pathophysiological mechanisms for steroid effects may
be related to the anti-inﬂammatory action, edema reduction,
or shrinkage of connective tissue. Local steroid application
was found to suppress transmission in thin unmyelinated C ﬁ-
bers [19].
It has been suggested that steroids may bind directly to the
intracellular glucocorticoid receptor, and their effects are pre-
dominantly mediated through altered protein gene transcrip-
tion [20]. The current study indicates that dexamethasone
has no effect on the onset of akinesia in peribulbar block; this
is because the action of dexamethasone starts after 1–2 h of its
administration.
Also, our study showed that peribulbar block with dexa-
methasone led to signiﬁcantly prolonged duration of akinesia
with prolonged postoperative analgesia and time to ﬁrst rescue
analgesia. In support of the direct effect of dexamethasone,
Shrestha et al. [21] found that dexamethasone added to local
anesthetic prolongs postoperative analgesia signiﬁcantly com-
pared with tramadol when used as an admixture to a local
anesthetic in brachial plexus block in upper extremity surgery,
and Parrington et al. [22] also found that the addition of dexa-
methasone to mepivacaine prolongs the duration of analgesia
but does not reduce the onset of sensory and motor blockade
after ultrasound guided supraclavicular block compared with
mepivacaine alone.
Furthermore, the analgesic efﬁcacy of dexamethasone was
found not to be related to the route of administration, this
was supported by multiple studies that reported an analgesiceffect after intravenous dexamethasone [23,24]. Others re-
ported its analgesic effect after epidural administration [25].
Only one patient in the bupivacaine dexamethasone group
experienced nausea and vomiting. The mechanism by which
glucocorticoids alleviated nausea and vomiting is centrally
mediated through inhibition of the release of endogenous opi-
oids. Other suggested mechanisms include central or peripheral
inhibition of the production or secretion of serotonin and
change in permeability of the blood brain barrier to serum pro-
tein [26].
Some surgeons have some fears about steroids as it may
mask the clinical signs of infection. However, since the biolog-
ical half-life of dexamethasone is 36–58 h, it is normal for a
postoperative wound to be re-dressed at 1 week, where by this
time the corticosteroids would have been totally eliminated
from the body [9].
Immediately after surgical incision, inﬂammatory, hor-
monal, immune and metabolic response are activated, so
administration of steroids may decrease these responses by
their anti-inﬂammatory and immunosuppressive effects by
inhibiting cyclooxygenase enzyme and phospholipase A2
[27]. This was evident with the reduction of C-reactive protein
levels in dexamethasone group than bupivacaine group alone.
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From our study, we concluded that adding dexamethasone to
bupivacaine as an adjuvant in peribulbar block provided more
prolonged duration of akinesia and analgesia with reduced
number of patients requiring analgesia and time to ﬁrst analge-
sic rescue dose and reduced inﬂammatory response as well.
Nevertheless, further studies are required before establishing
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